Ernexa Therapeutics joins Virtual Investor Closing Bell Series webcast
Ernexa Therapeutics will join the Virtual Investor Closing Bell Series on Oct. 15, 2026 at 4:00 p.m. ET. Management plans a corporate update, outlining strategy for its cell-therapy platform and progress of lead program ERNA-101 toward clinical development. Disclaimer: This news brief was created by Public Technologies